Masimo Corporation (MASI)
NGM – Real vaqt narxi. Valyuta: USD
179.95
+179.95 (0.00%)
Yopilishda: Jun 9, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
179.95
+179.95 (0.00%)
Yopilishda: Jun 9, 2026, 4:00 PM EDT
Masimo korporatsiyasi dunyo bo'ylab turli bemorlarni monitoring qilish texnologiyalarini, shuningdek, avtomatlashtirish va ulanish echimlarini ishlab chiqish, ishlab chiqarish va sotish bilan shug'ullanadi. U an'anaviy puls oksimetriyasining asosiy cheklovlarini bartaraf etish uchun harakat va past perfuziya paytida puls oksimetriyasini o'lchash imkonini beruvchi Masimo Signal Extraction Technology (SET) puls oksimetriyasini taklif etadi; kislorod, karboksihemoglobin va methemoglobinni nostimulyatsion monitoring qilish imkonini beruvchi rainbow SET Pulse CO-Oximetry mahsulotlarini o'z ichiga olgan Masimo Rainbow SET platformasi. Shuningdek, u miya faoliyati va gemodinamik monitoring echimlarini; bemorning holati va faoliyatini kuzatish, hamda neyromodulyatsiya texnologiyasi echimlarini taqdim etadi; va Masimo Hospital Automation platformasini, shu jumladan Patient SafetyNet, Iris, iSirona, Replica va UniView kabi kasalxona avtomatlashtirish echimlarini; shuningdek, miya faoliyatini monitoring qilish, gemodinamik monitoring, mintaqaviy oksimetriya, akustik nafas olish tezligini monitoring qilish, kapnografiya va gaz monitoringi, hamda telemeditsina echimlarini taqdim etadi. Bundan tashqari, kompaniya o'z mahsulotlarini to'g'ridan-to'g'ri savdo xodimlari, distribyutorlar va original uskunalar ishlab chiqaruvchilari hamkorlari orqali kasalxonalar, tez tibbiy yordam xizmatlari va uyda parvarishlash provayderlari, uzoq muddatli parvarishlash muassasalari, shifokor kabinetlari, veterinarlar va iste'molchilarga yetkazib beradi. Masimo korporatsiyasi 1989 yilda tashkil etilgan va Kaliforniyaning Irvin shahrida joylashgan. 2026 yil 10-iyun holatiga ko'ra, Masimo korporatsiyasi Danaher Corporation kompaniyasining sho'ba korxonasi sifatida faoliyat yuritadi.
| Ism | Lavozim |
|---|---|
| Dr. Steven J. Barker | Chairman of Scientific Advisory Board & Chief Science Officer |
| Mr. Anand Sampath | Executive Vice President of Operations |
| Mr. Charles Dadswell | Executive VP & General Counsel |
| Mr. Greg Meehan | Chief Commercial Officer |
| Mr. Matthew Brinckman | Senior Vice President of FP&A and Investor Relations |
| Mr. Micah Young CPA | Executive VP & CFO |
| Mr. Paul Hataishi | Senior VP & Chief Accounting Officer |
| Mr. Tim A. Benner | Chief Marketing & Strategy Officer |
| Mr. Yongsam Lee | Executive VP & Chief Information Officer |
| Ms. Catherine M. Szyman | CEO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-10 | POSASR | tm2617399d1_s3asr.htm |
| 2026-06-10 | 8-K | tm2617395d1_8k.htm |
| 2026-05-27 | SD | masi-20260529xformsd.htm |
| 2026-05-05 | 10-Q | masi-20260404.htm |
| 2026-05-04 | 8-K | tm2612557d3_8k.htm |
| 2026-05-01 | 10-K/A | masi-20260103x10ka.htm |
| 2026-04-23 | DEFA14A | tm2612557d2_defa14a.htm |
| 2026-04-23 | 8-K | tm2612557d1_8k.htm |
| 2026-04-01 | DEFM14A | tm268869-3_defm14a.htm |
| 2026-03-18 | PREM14A | tm268869-1_prem14a.htm |